Oxidative stress‐induced angiogenesis is mediated by miR‐205‐5p

M Oltra, L Vidal‐Gil, R Maisto… - Journal of cellular …, 2020 - Wiley Online Library
Abstract miR‐205‐5p is known to be involved in VEGF‐related angiogenesis and seems to
regulate associated cell signalling pathways, such as cell migration, proliferation and …

Knockdown of Malat1 alleviates high-glucose-induced angiogenesis through regulating miR-205-5p/VEGF-A axis

A Tan, T Li, L Ruan, J Yang, Y Luo, L Li, X Wu - Experimental eye research, 2021 - Elsevier
Diabetic retinopathy (DR), characterized by intraretinal vessel formation, is a major
complication in diabetes. Neovascularization is an important characteristic of DR, but its …

[HTML][HTML] Impact of anti-VEGF treatment and patient characteristics on vision outcomes in neovascular age-related macular degeneration: up to 6-year analysis of the …

CC Wykoff, V Garmo, D Tabano, A Menezes, E Kim… - Ophthalmology …, 2024 - Elsevier
Purpose To evaluate anti-VEGF treatment patterns and the influence of patient demographic
and clinical characteristics on up to 6-year vision outcomes in neovascular age-related …

Management of Neovascular Age-Related Macular Degeneration Treatment in France from 2008–2018: The Nationwide LANDSCAPE Study

CP Creuzot Garcher, M Srour, F Baudin, C Dot… - Ophthalmology and …, 2023 - Springer
Introduction The aim of this study was to describe the management of neovascular age-
related macular degeneration (nAMD) in French patients between 2008 and 2018. Methods …

Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study

HL Jeon, SJ Byun, NL Pratt, J Sultana… - British Journal of …, 2021 - bjo.bmj.com
Aims To identify the association between ranibizumab and risk of stroke and acute
myocardial infarction (AMI) in patients with exudative age-related macular degeneration …

[PDF][PDF] Real-life neovascular AMD treatment considering reimbursement in Turkiye: One-year comparison of switching to intravitreal ranibizumab or aflibercept after …

MO Sevik, NZ Tiras, A Aykut, DD Yigit… - Northern Clinics of …, 2024 - jag.journalagent.com
ABSTRACT OBJECTIVE: To compare one-year anatomical and functional results of
switching to an on-label intravitreal anti-vascular endothelial growth factor (anti-VEGF) agent …

[PDF][PDF] Study of the microRNA expression profile dysregulation by hydrogen peroxide on the retinal pigment epithelium cells: role of miR-205-5p

MO Sanchis - core.ac.uk
Figure 24. sEVs miRNAs validation in ARPE-19 cells....-111-Figure 25. miR-205-5p protein
target related pathways...-113-Figure 26. miR-521 protein target related pathways.........-114 …

[HTML][HTML] Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to …

S Zuccarini, F Puce, A Crisà - Drug Target Insights, 2022 - ncbi.nlm.nih.gov
Methods: We report here a case series of nAMD patients not responding to previous anti-
VEGF therapy showing anatomical and functional response to a single intravitreal injection …

Switching between aflibercept and ranibizumab in the treatment of refractory exudative age-related macular degeneration

M Wichrowska, J Kocięcki… - OphthaTherapy. Therapies …, 2021 - journalsmededu.pl
Introduction: Aflibercept and ranibizumab have become the most used drugs in the treatment
of wet age-related macular degeneration. Some patients; however, do not respond to …

[引用][C] Management of Neovascular Age-Related Macular Degeneration Treatment in France from 2008–2018: The Nationwide LANDSCAPE Study

CPCGM Srour, F Baudin, CDSNB Jean, F Girmens… - 2023 - europepmc.org
Introduction: The aim of this study was to describe the management of neovascular
agerelated macular degeneration (nAMD) in French patients between 2008 and 2018 …